RESUMO
Thyroid transcription factor 1 (TTF-1) was identified for its critical role in thyroid-specific gene expression; its level in the thyroid is regulated by thyrotropin-increased cyclic AMP levels. TTF-1 was subsequently found in lung tissue, where it regulates surfactant expression, and in certain neural tissues, where its function is unknown. Ligands or signals regulating TTF-1 levels in lung or neural tissue are unknown. We recently identified TTF-1 in rat parafollicular C cells and parathyroid cells. In this report, we show that TTF-1 is present in the parafollicular C cells of multiple species and that it interacts with specific elements on the 5'-flanking regions of the extracellular Ca2+-sensing receptor (CaSR), calmodulin, and calcitonin genes in C cells. When intracellular Ca2+ levels are increased or decreased in C cells, by the calcium ionophore A23187, by physiologic concentrations of the P2 purinergic receptor ligand ATP, or by changes in extracellular Ca2+ levels, the promoter activity, RNA levels, and binding of TTF-1 to these genes are, respectively, decreased or increased. The changes in TTF-1 inversely alter CaSR gene and calcitonin gene expression. We show, therefore, that TTF-1 is a Ca2+-modulated transcription factor that coordinately regulates the activity of genes critical for Ca2+ homeostasis by parafollicular C cells. We hypothesize that TTF-1 similarly coordinates Ca2+-dependent gene expression in all cells in which TTF-1 and the CaSR are expressed, i. e., parathyroid cells, neural cells in the anterior pituitary or hippocampus, and keratinocytes.
Assuntos
Cálcio/metabolismo , Regulação da Expressão Gênica/genética , Homeostase/genética , Proteínas Nucleares/genética , Glândula Tireoide/fisiologia , Fatores de Transcrição/genética , Animais , Sequência de Bases , Sítios de Ligação , Células Cultivadas , Proteínas de Ligação a DNA/genética , Imuno-Histoquímica , Hibridização In Situ , Dados de Sequência Molecular , Proteínas Nucleares/análise , Oligonucleotídeos Antissenso , Regiões Promotoras Genéticas/genética , RNA Mensageiro/genética , Ratos , Receptores de Detecção de Cálcio , Receptores de Superfície Celular/genética , Fator Nuclear 1 de TireoideRESUMO
Cases of acromegaly due to GHRHproducing pancreatic endocrine tumors have been reported. Here we present a case of a 31-yr-old nonacromegalic man with hyperparathyroidism and elevated serum IGF-I with normal serum GH levels. Serum GH was not suppressed below 1 ng/ml by the glucose tolerance test and increased in response to TR H and GHRH administration. Magnetic resonance imaging (MRI) revealed pituitary hyperplasia and an abdominal computed tomography (CT ) scan showed a tumor in the pancreatic tail. Plasma concentration of GHRH was elevated. Based on these clinical data, multiple endocrine neoplasia (MEN) type 1 was suspected. Three enlarged parathyroid glands were removed and a distal pancreatectomy was performed. Pathological examination of the parathyroid glands and pancreatic tumor showed nodular hyperplasia and a well-differentiated endocrine tumor, respectively, both compatible with MEN features. Immunohistochemistry revealed positive immunoreactivity for GHRH, SS , insulin, glucagon, chromogranin A, and pancreatic polypeptide in the pancreatic tumor. After pancreatic surgery, elevated levels of GHRH and IGF-I were normalized and pituitary hyperplasia definitely decreased in size. In cases of pituitary hyperplasia with elevated IGF-I, ectopic GHRH syndrome must be considered even if physical features of acromegaly are absent. It is also important to measure plasma GHRH concentrations in order to give a diagnosis.
Assuntos
Hormônio Liberador de Hormônio do Crescimento/metabolismo , Neoplasia Endócrina Múltipla Tipo 1/complicações , Neoplasias Pancreáticas/complicações , Neoplasias Pancreáticas/metabolismo , Acromegalia , Adulto , Hormônio do Crescimento Humano/sangue , Humanos , Hiperplasia , Hipertireoidismo/complicações , Hipertireoidismo/patologia , Fator de Crescimento Insulin-Like I/metabolismo , Imageamento por Ressonância Magnética , Masculino , Neoplasia Endócrina Múltipla Tipo 1/diagnóstico por imagem , Neoplasia Endócrina Múltipla Tipo 1/patologia , Neoplasias Pancreáticas/diagnóstico por imagem , Doenças da Hipófise/patologia , Tomografia Computadorizada por Raios XRESUMO
PC12 cells, a rat pheochromocytoma cell line, has been reported to release norepinephrine in response to extracellular ATP in the presence of extracellular Ca2+. The potency order of ATP analogues was adenosine 5'-O-(3-thiotriphosphate) greater than ATP greater than adenosine 5'-O-(1-thiotriphosphate) = 2-methylthioadenosine 5'-triphosphate (MeSATP) greater than 2'- and 3'-O-(4-benzoyl-benzoyl)ATP (BzATP) greater than ADP greater than 5-adenylylimidodiphosphate. Adenosine 5'-O-(2-thiodiphosphate), beta, gamma-methyleneadenosine 5'-triphosphate, AMP and adenosine were inactive. The ATP action in the absence of extracellular Ca2+, suggests a small but appreciable contribution of intracellular Ca2+ mobilization, for norepinephrine release. However, for some ATP derivatives, like BzATP, almost no contribution of the phospholipase C-Ca2+ pathway is suggested, based on their low activity in inositol phosphates production. To identify the ATP-receptor protein, PC12 cell membranes were photoaffinity-labeled with [32P]BzATP. SDS-PAGE analysis showed that a 53-kDa protein labeling was inhibited by ATP and its derivatives, as well as by P2-antagonists, suramin and reactive blue 2, which inhibit the nucleotide-induced norepinephrine release. The inhibitory activity of the nucleotides was, in parallel with their potency, to induce norepinephrine release. Despite their inability to release norepinephrine, GTP and GTP gamma S inhibited the BzATP labeling, suggesting the participation of a putative G protein in the ATP-receptor-mediated actions. We suggest that the 53-kDa protein on the PC12 cell surface is an ATP receptor, which mediates the norepinephrine release, depending, mainly, on extracellular Ca2+ gating.
Assuntos
Norepinefrina/metabolismo , Células PC12/efeitos dos fármacos , Receptores Purinérgicos/efeitos dos fármacos , Trifosfato de Adenosina/análogos & derivados , Trifosfato de Adenosina/antagonistas & inibidores , Trifosfato de Adenosina/farmacologia , Marcadores de Afinidade , Animais , Ligação Competitiva , Bradicinina/farmacologia , Cálcio/farmacologia , Canais de Cálcio/metabolismo , Guanosina 5'-O-(3-Tiotrifosfato)/farmacologia , Guanosina Trifosfato/farmacologia , Fosfatos de Inositol/metabolismo , Células PC12/metabolismo , Cloreto de Potássio/farmacologia , Ratos , Receptores Purinérgicos/metabolismo , Suramina/farmacologia , Triazinas/farmacologiaRESUMO
The chimeric chloramphenicol acetyltransferase (CAT) construct, pTRCAT5'-199, containing the TSH receptor (TSHR) minimal promoter, -199 to -39 base pairs (bp), exhibits the thyroid specificity and TSH/cAMP autoregulation evident in TSHR gene expression. The present report shows that a cis-acting element between -189 and -175 bp, which binds thyroid transcription factor-1 (TTF-1), is involved in both activities. The 22 bp between -199 and -178 contains a positive element important for expression of the TSHR minimal promoter in rat FRTL-5 thyroid cells. DNAase I footprinting shows that extracts from functioning FRTL-5, but not non-functioning FRT thyroid or Buffalo rat liver (BRL) cells, protect a region between -189 and -175 bp. The protection is duplicated by TTF-1, and the protected element has only a two-base mismatch from the consensus TTF-1 element identified in the thyroglobulin (TG) and thyroid peroxidase minimal promoters. Gel mobility shift analyses reveal that FRTL-5 thyroid cell nuclear extracts form a specific protein/DNA complex with this region, which is prevented by the TTF-1 binding element from the TG promoter; FRT and BRL cell nuclear extracts do not have TTF-1 and do not form this complex. A role for the TSHR/TTF-1 binding element in thyroid-specific expression of the TSHR gene is evidenced as follows. Overexpression of TTF-1 in FRT or BRL cells, which have no TTF-1, increased the activity of pTRCAT5'-199, but not pTRCAT5'-177, which has no TTF-1 binding element. A nonsense mutation of the TTF-1 binding element eliminated TTF-1-induced activation of TSHR promoter activity in FRT or BRL cells and reduced TSHR promoter activity in FRTL-5 thyroid cells. In contrast, mutation of this element to the TTF-1 consensus sequence of the TG or thyroid peroxidase promoter had no significant influence on TSHR promoter activity. The activity of the TSHR/TTF-1 binding element requires a functioning cAMP response element (CRE). Thus, TTF-1 activity is lost when the CRE site is mutated to a nonfunctional, nonpalindromic sequence; it is, in contrast, maximized when CRE activity is maximized by its mutation to a consensus AP1 element. TTF-1 phosphorylation is important for binding and activity. Thus, binding of TTF-1 to the TSHR/TTF-1 element is phosphatase-sensitive and is increased by treating nuclear extracts with the catalytic subunit of protein kinase A. Overexpression of the catalytic subunit of PKA enhances TTF-1-increased activity of the TSHR minimal promoter.(ABSTRACT TRUNCATED AT 400 WORDS)
Assuntos
AMP Cíclico/fisiologia , Proteínas Nucleares/fisiologia , Receptores da Tireotropina/genética , Transdução de Sinais/fisiologia , Glândula Tireoide/metabolismo , Tireotropina/metabolismo , Fatores de Transcrição/fisiologia , Animais , Sequência de Bases , Sequência Consenso , Proteínas Quinases Dependentes de AMP Cíclico/fisiologia , Substâncias Macromoleculares , Dados de Sequência Molecular , Especificidade de Órgãos , Fosforilação , Regiões Promotoras Genéticas , Processamento de Proteína Pós-Traducional , Ratos , Ratos Endogâmicos BUF , Receptores da Tireotropina/biossíntese , Proteínas Recombinantes de Fusão/biossíntese , Sequências Reguladoras de Ácido Nucleico , Fator Nuclear 1 de Tireoide , Transcrição Gênica , Células Tumorais CultivadasRESUMO
TSH and immunoglobulin G (IgG) preparations from patients with Graves' disease increase inositol phosphate as well as cAMP formation in Cos-7 cells transfected with rat TSH receptor (TSHR) cDNA. In a previous report, we mutated alanine 623 of the third cytoplasmic loop (residues 605-625) of the TSHR and showed it was critical for TSH and Graves' IgG initiation of phosphatidylinositol bisphosphate (PIP2) but not cAMP signaling. In this report, we substituted residues in the third loop of the TSHR with sequences from the N- and C-termini of the third loop of the alpha 1- and beta 2-adrenergic receptors (ARs), which computer analysis has identified as homologous to those in the TSHR. Alanine 623 is conserved in most ARs as well as in glycoprotein hormone receptors; there is, therefore, no change in alanine 623. After transfection of the mutant TSHR cDNAs into Cos-7 cells, we show that the mutant proteins are normally synthesized, processed, and incorporated into the membrane bilayer by Western blotting with a specific receptor antibody. We also show that the dissociation constant for TSH binding in all mutants is the same or lower than wild type TSHR. We then evaluated the ability of TSH or Graves' IgG to increase PIP2 and cAMP signals in each transfectant. Mutants A622 and B621 replace, respectively, residues 622-625 and 621-625 of the TSHR with alpha 1- and beta 2-AR residues from the C-terminus of the third cytoplasmic loop; mutants A607 and B605 replace, respectively, TSHR residues 607-609 and 605-609 with N-terminus residues from alpha 1- and beta 2-AR. All four mutants, like the alanine 623 mutant, result in transfected cells which lose TSH and Graves' IgG initiation of PIP2 but not cAMP signalling. Like the alanine 623 mutation to glutamic acid, the A607, B605, A622, and B621 mutants also result in decreased basal cAMP, but not inositol phosphate levels, relative to wild type receptor. In contrast to these results, mutants A610, B610, A617, and B617, which replace residues 610-613 or 617-620 of the TSHR with corresponding residues of the alpha 1- and beta 2-AR, retain TSH and Graves' IgG responsiveness in both inositol phosphate and cAMP assays. Mutation of residues 610-613, in fact, potentiates TSH-increased inositol phosphate production, despite having no effect on TSH-increased cAMP production.(ABSTRACT TRUNCATED AT 250 WORDS)
Assuntos
Autoanticorpos/farmacologia , AMP Cíclico/fisiologia , Fosfatos de Fosfatidilinositol/fisiologia , Estrutura Terciária de Proteína , Receptores da Tireotropina/química , Transdução de Sinais , Tireotropina/farmacologia , Sequência de Aminoácidos , Animais , Linhagem Celular , Chlorocebus aethiops , Fibroblastos , Doença de Graves/imunologia , Humanos , Imunoglobulina G/farmacologia , Imunoglobulinas Estimuladoras da Glândula Tireoide , Modelos Moleculares , Dados de Sequência Molecular , Mutagênese Sítio-Dirigida , Fosfatidilinositol 4,5-Difosfato , Receptores Adrenérgicos/genética , Receptores da Tireotropina/genética , Receptores da Tireotropina/imunologia , Receptores da Tireotropina/fisiologia , Proteínas Recombinantes de Fusão/metabolismo , TransfecçãoRESUMO
Exposure of FRTL-5 thyroid cells to ATP (1 microM to 1 mM) resulted in the stimulation of I- efflux in association with the induction of inositol trisphosphate production and intracellular Ca2+ mobilization. Nonhydrolyzable ATP derivatives, ADP and GTP, were also as effective in magnitude as ATP, whereas neither AMP nor adenosine exerted significant effect on I- efflux, suggesting a P2-purinergic receptor-mediated activation of I- efflux. Treatment of the cells with the islet-activating protein (IAP) pertussis toxin, which ADP-ribosylated a 41,000 mol wt membrane protein, effectively suppressed the phosphoinositide response to ATP in addition to ATP-dependent I- efflux at agonist concentrations below 10 microM. In contrast, the I- efflux stimulated by TSH, A23187, or phorbol myristate acetate was insusceptible to IAP. The IAP substrate, probably GTP-binding protein, is hence proposed to mediate the activation of P2-purinergic receptor-linked phospholipase-C in FRTL-5 cells. However, the responses to ATP, its nonhydrolyzable derivatives, or ADP at the higher agonist concentrations, especially above 100 microM, were only partially inhibited by IAP, even though the IAP substrate was totally ADP ribosylated by the toxin. The responses to GTP in the whole concentration range tested were not influenced by IAP treatment. Thus, signals arising from the P2-receptor might be transduced to phospholipase-C by two different pathways, i.e. IAP-sensitive and insensitive ones, and result in the stimulation of I- efflux.
Assuntos
Iodetos/metabolismo , Toxina Pertussis , Fosfatidilinositóis/metabolismo , Receptores Purinérgicos/metabolismo , Glândula Tireoide/metabolismo , Fatores de Virulência de Bordetella/farmacologia , Nucleotídeos de Adenina/farmacologia , Adenosina Difosfato Ribose/metabolismo , Trifosfato de Adenosina/farmacologia , Animais , Calcimicina/farmacologia , Cálcio/metabolismo , Cálcio/farmacologia , Linhagem Celular , Citosol/metabolismo , Guanosina Trifosfato/farmacologia , Fosfatos de Inositol/biossíntese , Radioisótopos do Iodo , Peso Molecular , Ratos , Receptores Purinérgicos/efeitos dos fármacos , Acetato de Tetradecanoilforbol/farmacologia , Glândula Tireoide/efeitos dos fármacos , Tireotropina/farmacologiaRESUMO
TSH-induced intracellular Ca2+ concentration ([Ca2+]i) changes in single FRTL-5 thyroid cells were analyzed by digital video imaging of fura-2-loaded cells. More than 80% of the cells responded to as little as 30 nM TSH, resulting in a [Ca2+]i rise in the presence and absence of extracellular Ca2+. One micromolar concentration of N6-(L-2-phenylisopropyl)adenosine (PIA) caused no appreciable [Ca2+]i increase in more than 300 cells examined, but induced the [Ca2+]i elevation in more than 90% of the cells that had previously been treated with TSH. Pertussis toxin treatment abolished the PIA, but not the TSH, action, whereas thapsigargin-induced Ca2+ depletion of the inositol 1,4,5-trisphosphate-sensitive pool inhibited the actions of both TSH and PIA. The time courses of Ca2+ response considerably differentiated among single cells, but showed similarity among different areas in each cell. These results suggest that PIA induces Ca2+ release from the same thapsigargin-sensitive pool as that targeted by TSH. The lack of PIA stimulation of basic fibroblast growth factor-induced phospholipase-C gamma activation as well as the rise in [Ca2+]i suggests that the cooperative PIA action occurs specifically on phospholipase-C beta.
Assuntos
Cálcio/metabolismo , Fatores de Crescimento de Fibroblastos/farmacologia , Agonistas do Receptor Purinérgico P1 , Terpenos/farmacologia , Glândula Tireoide/metabolismo , Tireotropina/farmacologia , Animais , Células Cultivadas , Fura-2 , Processamento de Imagem Assistida por Computador , Toxina Pertussis , Ratos , Receptores Purinérgicos P1/metabolismo , Sensibilidade e Especificidade , Tapsigargina , Fatores de Tempo , Fatores de Virulência de Bordetella/farmacologiaRESUMO
We quantified the TSH-induced morphological change in FRTL-5 thyroid cells according to a morphological index corresponding to the mean cell area measured from microscopic photographs. Within 15 min, TSH induced, at 10 pM and higher concentrations, a decrease in morphological index together with a rise in cAMP levels in a TSH dose-dependent manner. Forskolin, 3-isobutyl-1-methylxanthine, and RO 20-1724, the latter two being phosphodiesterase inhibitors, mimicked these TSH effects, indicating that the rise in cAMP levels is responsible for the TSH effect. Extracellular ATP and its derivatives, known as purinergic receptor agonists, decreased cAMP levels and caused a complete reversal of the TSH morphological effect. Prior exposure of the cells to islet-activating protein (pertussis toxin), the depletion of extracellular Ca2+, or the addition of low doses of protein kinase-C inhibitors completely abolished the inhibitory action of ATP on the TSH effect, whereas phorbol 12-myristate 13-acetate, which activates protein kinase-C, mimicked the ATP action to some extent. Thus, although the TSH-induced change in cell morphology seems to be dependent on cAMP levels, the inhibition of TSH action by ATP seems to be mediated by at least two signal transduction pathways involving islet-activating protein substrate G-proteins: one inhibiting adenylate cyclase and the other involving Ca2+ and protein kinase-C.
Assuntos
Trifosfato de Adenosina/metabolismo , Espaço Extracelular/metabolismo , Glândula Tireoide/citologia , Tireotropina/farmacologia , Trifosfato de Adenosina/farmacologia , Toxina Adenilato Ciclase , Animais , Cálcio/fisiologia , Linhagem Celular , AMP Cíclico/metabolismo , Relação Dose-Resposta a Droga , Microscopia Eletrônica de Varredura , Toxina Pertussis , Proteína Quinase C/metabolismo , Ratos , Glândula Tireoide/efeitos dos fármacos , Glândula Tireoide/ultraestrutura , Tireotropina/antagonistas & inibidores , Fatores de Virulência de Bordetella/farmacologiaRESUMO
The production of hydrogen peroxide (H2O2) as an essential process for iodide organification is a key reaction in TSH-induced thyroid hormone synthesis. Here we characterize the signal transduction pathway involved in TSH-induced H2O2 production in FRTL-5 thyroid cells. At higher than 1 nM TSH, N6-(L-2-phenylisopropyl)adenosine (PIA), an adenosine receptor agonist having, by itself, no influence on H2O2 generation, potentiated this TSH action, whereas the TSH increase and PIA addition reduced cAMP accumulation. RO 20-1724, a phosphodiesterase inhibitor, amplified the TSH-induced cAMP accumulation, but did not change H2O2 generation in the whole range of TSH used. Ca(2+)-mobilizing agonists, GTP and ATP, also induced H2O2 production without stimulating cAMP accumulation. Chelation of intracellular Ca2+ markedly inhibited the TSH action, but intracellular Ca2+ increases by either thapsigargin or ionomycin mimicking it. All of the findings show the participation of Ca2+, but not cAMP, in the action of TSH. Desensitization of protein kinase-C (PKC) did not influence the receptor-mediated H2O2 production, suggesting the reduced importance of PKC activation compared to Ca2+ signaling to the reaction. A rise in intracellular Ca2+ independent of receptor activation also induced H2O2 production as well as arachidonate release, and both were potentiated by PIA. In addition, inhibitors of phospholipase-A2 and the arachidonate metabolic pathway depressed H2O2 generation, suggesting the participation of an arachidonate cascade in the Ca(2+)-dependent H2O2 production. Lipoxygenase inhibitors depressed the Ca2+ action without influencing arachidonate release, suggesting the involvement of a lipoxygenase product(s) of arachidonate in the Ca(2+)-signaling mechanism. In conclusion, in FRTL-5 cells, TSH-induced H2O2 production is mediated not by cAMP, but by the phospholipase-C/Ca2+ cascade, possibly followed by the Ca(2+)-dependent phospholipase-A2/arachidonate cascade. PIA amplifies TSH-induced H2O2 production at the steps of phospholipase-C and phospholipase-A2 activation in a pertussis toxin-sensitive manner.
Assuntos
Adenosina/análogos & derivados , Cálcio/metabolismo , Peróxido de Hidrogênio/metabolismo , Fosfolipases A/metabolismo , Glândula Tireoide/metabolismo , Tireotropina/farmacologia , Animais , Ácido Araquidônico/metabolismo , Linhagem Celular , AMP Cíclico/fisiologia , Ativação Enzimática , Proteínas de Ligação ao GTP/fisiologia , Toxina Pertussis , Fenilisopropiladenosina/farmacologia , Fosfolipases A2 , Proteína Quinase C/metabolismo , Ratos , Transdução de Sinais , Glândula Tireoide/citologia , Fatores de Virulência de Bordetella/farmacologiaRESUMO
FRTL-5 rat thyroid cells grown in culture medium supplemented with serum and 6H (TSH, insulin, hydrocortisone, transferrin, glycylhistidyllysine, and somatostatin) showed a significant increase in TSH-dependent cAMP accumulation and I- efflux after prolonged incubation (5 to 10 days) of the cells in culture medium containing 5H (6H - TSH) or serum. The induction of the cAMP response was at least partly reproduced when both serum and 5H were omitted from the medium. However the I- efflux response was completely abolished under such conditions and regenerated when serum or 5H was present. The serum or 5H effect on I- efflux response was mimicked by 2H (insulin + hydrocortisone). Insulin was replaced by 1/1000 less insulin-like growth factor-I than insulin. TSH-dependent Ca2+ mobilization of the cells was similarly affected by the presence of serum or 2H. However, the I- efflux and Ca2+ responses to an agonist other than TSH (extracellular ATP) were not substantially influenced by serum and/or 2H as well as TSH in the medium. The results indicate that serum or insulin-like growth factor-I plus hydrocortisone are required rather specifically for the regeneration of the TSH-receptor mechanism coupled with I- efflux and/or Ca2+ mobilization mechanism.
Assuntos
Cálcio/metabolismo , Hidrocortisona/farmacologia , Fator de Crescimento Insulin-Like I/farmacologia , Iodetos/metabolismo , Somatomedinas/farmacologia , Tireotropina/farmacologia , Animais , Benzofuranos , Linhagem Celular , AMP Cíclico/metabolismo , Citosol/metabolismo , Interações Medicamentosas , Fura-2 , Cinética , Ratos , Glândula Tireoide/efeitos dos fármacos , Glândula Tireoide/metabolismoRESUMO
Exogenous sphingosine 1-phosphate (S1P) stimulated hydrogen peroxide (H2O2) generation in association with an increase in intracellular Ca2+ concentration in FRTL-5 thyroid cells. S1P also induced inositol phosphate production, reflecting activation of phospholipase C (PLC) in the cells. These three S1P-induced events were inhibited partially by pertussis toxin (PTX) and markedly by U73122, a PLC inhibitor, and were conversely potentiated by N6-(L-2-phenylisopropyl)adenosine, an A1-adenosine receptor agonist. In FRTL-5 cell membranes, S1P also activated PLC in the presence of guanosine 5'-O-(3-thiotriphosphate) (GTP gamma S), but not in its absence. Guanosine 5'-O-(2-thiodiphosphate) inhibited the S1P-induced GTP gamma S-dependent activation of the enzyme. To characterize the signaling pathways, especially receptors and G proteins involved in the S1P-induced responses, cross-desensitization experiments were performed. Under the conditions where homologous desensitization occurred in S1P-, lysophosphatidic acid (LPA)-, and bradykinin-induced induction of Ca2+ mobilization, no detectable cross-desensitization of S1P and bradykinin was observed. This suggests that the primary action of S1P in its activation of the PLC-Ca2+ system was not the activation of G proteins common to S1P and bradykinin, but the activation of a putative S1P receptor. On the other hand, there was a significant cross-desensitization of S1P and LPA; however, a still significant response to S1P (50-80% of the response in the nontreated control cells) was observed depending on the lipid dose employed after a prior LPA challenge. S1P also inhibited cAMP accumulation in a PTX-sensitive manner. We conclude that S1P stimulates H2O2 generation through a PLC-Ca2+ system and also inhibits adenylyl cyclase in FRTL-5 thyroid cells. The S1P-induced responses may be mediated partly through a putative lipid receptor that is coupled to both PTX-sensitive and insensitive G proteins.
Assuntos
Cálcio/metabolismo , Proteínas de Ligação ao GTP/fisiologia , Peróxido de Hidrogênio/metabolismo , Metabolismo dos Lipídeos , Esfingosina/análogos & derivados , Glândula Tireoide/metabolismo , Fosfolipases Tipo C/metabolismo , Inibidores de Adenilil Ciclases , Animais , Bradicinina/farmacologia , Células Cultivadas , Ativação Enzimática , Guanosina 5'-O-(3-Tiotrifosfato)/farmacologia , Lisofosfolipídeos/farmacologia , Ratos , Esfingosina/farmacologia , Glândula Tireoide/citologiaRESUMO
BACKGROUND AND PURPOSE: Sphingosine 1-phosphate (S1P) is a platelet-derived bioactive lipid that exerts a variety of biological responses, including vasocontraction. To understand the involvement of S1P in cerebral vasospasm, we investigated the effect of S1P on vasocontraction of the canine basilar artery in vitro and in vivo. METHODS: We recorded isometric tension in basilar arterial rings from dogs in vitro and estimated time-course changes in the diameter of canine basilar arteries and the S1P concentration in cerebrospinal fluid (CSF) by angiography and radioreceptor assays, respectively, after administering S1P into the cisterna magna. Changes in the supernatant S1P concentration during clot formation were monitored by using the in vitro subarachnoid hemorrhage model, in which blood is mixed with CSF. RESULTS: At concentrations ranging between 100 nmol/L and 10 micromol/L, S1P induced a dose-dependent contraction of the basilar artery in vitro. This effect was significantly inhibited by Y-27632, a highly selective Rho-kinase inhibitor. The administration of S1P into the CSF induced a 60% to 70% decrease in the arterial diameter within 15 minutes, and vasocontraction continued for 2 days thereafter. The concentration of S1P in the supernatant during clot formation in vitro reached approximately 300 nmol/L. CONCLUSIONS: S1P induces vasocontraction in the canine basilar artery in vitro and in vivo, possibly through a mechanism involving activation of the Rho/Rho-kinase pathway. Thus, S1P might be considered as a novel spasmogenic substance involved in cerebral vasospasm after subarachnoid hemorrhage.
Assuntos
Artéria Basilar/efeitos dos fármacos , Artéria Basilar/fisiologia , Lisofosfolipídeos , Esfingosina/análogos & derivados , Esfingosina/farmacologia , Vasoconstrição/efeitos dos fármacos , Vasoespasmo Intracraniano , Amidas/farmacologia , Animais , Artéria Basilar/diagnóstico por imagem , Sangue/metabolismo , Angiografia Cerebral , Líquido Cefalorraquidiano/química , Líquido Cefalorraquidiano/metabolismo , Modelos Animais de Doenças , Cães , Relação Dose-Resposta a Droga , Inibidores Enzimáticos/farmacologia , Feminino , Técnicas In Vitro , Injeções Intraventriculares , Peptídeos e Proteínas de Sinalização Intracelular , Contração Isométrica/efeitos dos fármacos , Contração Isométrica/fisiologia , Masculino , Proteínas Serina-Treonina Quinases/antagonistas & inibidores , Piridinas/farmacologia , Ensaio Radioligante , Esfingosina/administração & dosagem , Esfingosina/antagonistas & inibidores , Esfingosina/metabolismo , Grau de Desobstrução Vascular/efeitos dos fármacos , Vasoconstrição/fisiologia , Vasoespasmo Intracraniano/diagnóstico , Vasoespasmo Intracraniano/etiologia , Quinases Associadas a rhoRESUMO
Immunoglobulins (IgG) from patients with Graves' disease increase inositol phosphate (IP) as well as cAMP production in rat thyroid FRTL-5 cells; IgGs from normal control subjects do not. Graves' IgG-and TSH-induced IP formation is inhibited by blocking TSH receptor (TSHR) antibodies from hypothyroid patients with primary myxedema, as is the cAMP response; this suggests that the Graves' IgG are acting through the TSHR to induce both the cAMP and phosphatidyl-inositol 4,5-biphosphate signal cascades in FRTL-5 thyroid cells as in cells with recombinant TSHR. Optimal conditions for measuring the Graves' IgG-induced IP increase include a NaCl-free Hanks' Balanced Salt Solution (HBSS) buffer system and a P1 purinergic receptor agonist; the action of each is additive. Optimization by NaCl-free HBSS is similar to that observed in cAMP assays and is specific for TSH or Graves' IgG; thus, NaCl-free HBSS did not affect ATP-induced, and actually inhibited norepinephrine-induced, IP production in FRTL-5 cells. The P1 purinergic receptor agonist acts via receptor cross-talk, which also allows further optimization of cAMP assays. Thus, adenosine deaminase improves Graves' IgG-induced cAMP production by removing adenosine from the medium. Although NaCl-free HBSS improved TSH- or Graves' IgG-induced IP and cAMP production in cells with recombinant TSHR; the modulatory action of phenylisopropyladenosine was lost.
Assuntos
Autoanticorpos/análise , Fosfatos de Inositol/metabolismo , Fenilisopropiladenosina/farmacologia , Receptores Purinérgicos/fisiologia , Receptores da Tireotropina/imunologia , Glândula Tireoide/metabolismo , Animais , Anticorpos/farmacologia , Linhagem Celular , AMP Cíclico/metabolismo , Doença de Graves/sangue , Imunoglobulinas/sangue , Imunoglobulinas/farmacologia , Ratos , Glândula Tireoide/citologia , Tireotropina/farmacologiaRESUMO
Bradykinin (BK) induced a transient and pertussis toxin (PT)-insensitive increase in cytosolic Ca2+ ([Ca2+]i) in NG 108-15 neuroblastoma x glioma hybrid cells, whereas leucine-enkephalin (EK), somatostatin, norepinephrine or carbachol showed a weak but PT-sensitive action. When any one of the latter agonists was applied to the cells treated with low doses of BK, however, the level of [Ca2+]i rise caused by the agonist was remarkably increased in a PT-sensitive manner. The decreasing of extracellular Ca2+ only slightly influenced the actions of these agonists. Thus, synergism between a BK receptor and PT-sensitive G-protein-coupled receptors results in marked intracellular Ca2+ mobilization by the latter agonists.
Assuntos
Bradicinina/farmacologia , Cálcio/metabolismo , Proteínas de Ligação ao GTP/metabolismo , Toxina Pertussis , Fatores de Virulência de Bordetella/farmacologia , Carbacol/farmacologia , Citosol/metabolismo , Sinergismo Farmacológico , Norepinefrina/farmacologia , Receptores de Neurotransmissores/efeitos dos fármacos , Receptores de Neurotransmissores/metabolismo , Somatostatina/farmacologia , Células Tumorais CultivadasRESUMO
Various adenine nucleotides activated phospholipase C of FRTL-5 cell membranes in the following order of activity, ATP gamma S greater than ATP greater than AppNp greater than AppCp = ADP greater than MeSATP. This order was well consistent with that observed in intact cells. Such activation occurred only in the presence of appropriate concentrations of GTP gamma S and Ca2+, in a way similar to the norepinephrine-induced activation. NaF, a non-specific GTP-binding protein (G-protein) activator, also stimulated the enzyme. These adenine nucleotides, norepinephrine and NaF-induced activations were inhibited by GDP beta S. We conclude that a G-protein is involved in the adenine nucleotides-induced activation of phospholipase C via P2-purinergic receptor in FRTL-5 cells.
Assuntos
Cálcio/fisiologia , Proteínas de Ligação ao GTP/fisiologia , Nucleotídeos de Guanina/fisiologia , Receptores Purinérgicos/fisiologia , Glândula Tireoide/fisiologia , Fosfolipases Tipo C/metabolismo , Adenilil Imidodifosfato/farmacologia , Animais , Linhagem Celular , Membrana Celular/metabolismo , Sistema Livre de Células , Ativação Enzimática , Técnicas In Vitro , Fosfatos de Inositol/metabolismo , Norepinefrina/farmacologia , Ratos , Receptores Adrenérgicos alfa/fisiologia , Fluoreto de Sódio/farmacologiaRESUMO
Norepinephrine (NE) stimulated FRTL-5 thyroid cells via an alpha 1-adrenergic receptor, resulting in cytosolic Ca2+ [( Ca2+]i) mobilization and activation of phospholipase C. Adenosine and its receptor agonist, phenylisopropyladenosine (PIA), although not exerting a direct effect, markedly enhanced the NE-induced changes. Basal NE action was not totally abolished whereas the permissive action of adenosine and PIA was completely abolished by pretreatment of the cells with islet-activating protein (IAP), pertussis toxin. The decrease in cAMP level induced by adenosine or PIA is not the cause of their permissive effect, since the effect was not reversed by the addition of cAMP-increasing agents. We conclude that an IAP substrate GTP-binding protein(s) plays a novel role in forming a stimulatory coupling between an adenosine receptor and an alpha 1-adrenergic receptor-coupled phospholipase C system.
Assuntos
Cálcio/metabolismo , Toxina Pertussis , Receptores Adrenérgicos alfa/fisiologia , Receptores Purinérgicos/efeitos dos fármacos , Glândula Tireoide/metabolismo , Fosfolipases Tipo C/metabolismo , Fatores de Virulência de Bordetella/farmacologia , Adenosina/farmacologia , Animais , Linhagem Celular , Citosol/metabolismo , Relação Dose-Resposta a Droga , Sinergismo Farmacológico , Ativação Enzimática , Proteínas de Ligação ao GTP/metabolismo , Norepinefrina/farmacologia , Fenilisopropiladenosina/farmacologia , Ratos , Receptores Purinérgicos/fisiologia , Glândula Tireoide/efeitos dos fármacosRESUMO
Acute spontaneous c-myc gene expression and sustained increase of a GTP-binding protein(s) (G-protein) which is sensitive to islet-activating protein (IAP), pertussis toxin, occurred early during primary culture of adult rat hepatocytes. Following these earlier events, DNA synthesis was demonstrated in response to EGF and insulin. Addition of IAP immediately after plating of primary cultures inhibited c-myc expression and the hormone-induced DNA synthesis. Addition at 24 h or later following cell inoculation, however, produced only weak effects on DNA synthesis, even though the IAP-sensitive G-proteins were completely inactivated. We conclude that the IAP-sensitive G-protein(s) plays a role in the earlier process(es) of the G0-G1 transition, which is essential for the initiation of growth factor-dependent DNA synthesis.
Assuntos
Proteínas de Ligação ao GTP/fisiologia , Interfase , Fígado/citologia , Toxina Pertussis , Fatores de Virulência de Bordetella/farmacologia , Adenosina Difosfato Ribose/metabolismo , Animais , Células Cultivadas , DNA/biossíntese , Fator de Crescimento Epidérmico/farmacologia , Insulina/farmacologia , Fígado/efeitos dos fármacos , Fígado/metabolismo , Masculino , Proteínas Proto-Oncogênicas/genética , Proteínas Proto-Oncogênicas c-myc , RNA Mensageiro/biossíntese , Ratos , Ratos EndogâmicosRESUMO
We transfected the COS-7 cells with cDNAs encoding different human somatostatin receptor (hSSTR) subtypes, and found that hSSTR subtypes mediate not only the inhibition of forskolin-induced cAMP accumulation but also the stimulation of phospholipase C (PLC) and Ca2+ mobilization. Activation of PLC by 1 microM somatostatin (SRIF) was in the order of: hSSTR5 > hSSTR2 > hSSTR3 > hSSTR4 >> hSSTR1. Pertussis toxin (PTX) treatment completely or partially reversed the PLC activation. 1 nM SRIF was equally effective for adenylate cyclase (AC) inhibition in a PTX-sensitive manner, in all the cells expressing different hSSTRs, except for hSSTR1. Nevertheless, SRIF stimulated AC even in the presence of forskolin at higher doses of SRIF in PTX-treated hSSTR5-expressing cells. We conclude that the cloned hSSTRs differentially couple to PTX-sensitive and -insensitive G-proteins to modulate PLC, Ca2+ mobilization and AC.
Assuntos
Cálcio/metabolismo , Receptores de Somatostatina/metabolismo , Fosfolipases Tipo C/metabolismo , Linhagem Celular , Clonagem Molecular , Colforsina/farmacologia , AMP Cíclico/metabolismo , Ativação Enzimática , Humanos , Receptores de Somatostatina/genética , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismoRESUMO
Exogenous sphingosine 1-phosphate (S1P) induced Ca2+ mobilization, in association with an increase in inositol polyphosphate production reflecting activation of phospholipase C in HL60 leukemia cells. The increase in intracellular Ca2+ concentration ([Ca2+]i) induced by S1P was inhibited by an appropriate treatment of the cells with pertussis toxin (PTX), U73122 (a phospholipase C inhibitor) or phorbol 12-myristate 13-acetate (PMA). In parallel with the Ca2+ response, these agents also inhibited inositol polyphosphate production. The S1P-induced Ca2+ response was also attenuated in the dibutyryl cAMP-induced differentiated cells, where GTP-binding protein-induced Ca2+ response suggested to be enhanced. Lysophosphatidic acid (LPA) also increased [Ca2+]i in the cels, but the maximal response was about half of that of S1P, and furthermore PTX and dibutyryl cAMP treatment hardly affected the LPA-induced Ca2+ mobilization. We conclude that exogenous S1P mobilizes Ca2+ through phospholipase C activation. The S1P-induced enzyme activation is at least partly mediated by PTX-sensitive GTP-binding protein-coupled receptors which may be different from LPA receptors.
Assuntos
Cálcio/metabolismo , Proteínas de Ligação ao GTP/metabolismo , Lisofosfolipídeos , Toxina Pertussis , Esfingosina/análogos & derivados , Fosfolipases Tipo C/metabolismo , Fatores de Virulência de Bordetella/metabolismo , Ativação Enzimática , Células HL-60 , Humanos , Fosfatos de Inositol/biossíntese , Leucemia , Esfingosina/farmacologiaRESUMO
Exposure of various neural cells to ATP increased intracellular Ca2+ and the production of inositol trisphosphate. The Ca2+ responses were also observed in the absence of extracellular Ca2+, suggesting that a part of Ca2+ mobilization took place from cytosolic storage. Since adenosine had no effect on intracellular Ca2+ increment, ATP appears to act through a P2-purinergic receptor. Islet-activating protein or pertussis toxin pretreatment hardly influenced the increase in intracellular Ca2+ and inositol trisphosphate production induced by ATP, suggesting that IAP-sensitive GTP-binding proteins do not play a practical role in this reaction.